Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer
Cancers · 07.01.2025 · 17 (2) · 170
DOI: 10.3390/cancers17020170 ↗Kurz gefasst
Leitlinie in der Zeitschrift Cancers, online erschienen am 07.01.2025. Verfasst von Jonathan Ejie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
Comprehensive evaluation of guideline-concordant care (GCC) across all PDAC stages has yet to be thoroughly conducted. This study aimed to characterize treatment patterns and assess factors associated with receiving GCC among patients with pancreatic ductal adenocarcinoma (PDAC) in California. (2)
Methods
Data on adult patients with PDAC were extracted from the California Cancer Registry (2004–2020). GCC is defined according to the recommendations provided by the National Comprehensive Cancer Network. We used multivariable logistic regression to identify factors associated with receiving GCC. A Cox model was used to examine the association of GCC with overall survival. (3)
Results
A total of 50,346 PDAC patients were included (stage 1: 10%; stage 2: 25%; stage 3: 11%; stage 4: 54%). Only 46.7% of all patients received GCC (stage 1: 20%; stage 2: 40%; stage 3: 69%; stage 4: 50%). Only 31% of stage 1 patients underwent surgery. Factors inversely associated with receiving GCC were Hispanic ethnicity (OR 0.78; p < 0.001), Black race (OR 0.74; p < 0.001), having no insurance (OR 0.40; p < 0.001]), and a Charlson–Deyo score of ≥2 (OR 0.68; p < 0.001). Adherence to GCC was associated with improved survival (Hazard Ratio 0.39; p < 0.001). Notably, patients with stage 1 PDAC who received GCC had a median survival of 47 months vs. 8 months for those who did not. (4)
Conclusions
Although stage 1 PDAC patients have the greatest potential for survival with GCC, only 20% of patients received such treatment. Thus, it is crucial to identify and address the modifiable factors contributing to these suboptimal care patterns.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
- School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.
ORCID-Profile: Jonathan Ejie, Jaeyun Jane Wang
Zitieren
APA
Ejie, J., Ashraf Ganjouei, A., Hernandez, S., Wang, J. J., Romero-Hernandez, F., Foroutani, L., Hirose, K., Nakakura, E., Corvera, C. U., Alseidi, A., & Adam, M. A. (2025). Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. Cancers, 17(2), 170. https://doi.org/10.3390/cancers17020170
Vancouver
Ejie J, Ashraf Ganjouei A, Hernandez S, Wang JJ, Romero-Hernandez F, Foroutani L, et al. Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer. Cancers. 2025;17(2):170. doi:10.3390/cancers17020170
BibTeX
@article{Ejie2025,
author = {Ejie, Jonathan and Ashraf Ganjouei, Amir and Hernandez, Sophia and Wang, Jaeyun Jane and Romero-Hernandez, Fernanda and Foroutani, Laleh and Hirose, Kenzo and Nakakura, Eric and Corvera, Carlos Uriel and Alseidi, Adnan and Adam, Mohamed Abdelgadir},
title = {Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {2},
pages = {170},
doi = {10.3390/cancers17020170}
}
EUVIMED